The Rapidly Changing Landscape of Respiratory Syncytial Virus Prophylaxis
- Joan Robinson; Jesse Papenburg
Access Resources
About
The article describes the changing ways to prevent respiratory syncytial virus (RSV) in Canada. New methods include a monoclonal antibody called nirsevimab and vaccines for pregnant women to protect babies. Nirsevimab offers long-lasting protection with just one dose, while maternal vaccines help newborns by passing antibodies from mother to child. The article also mentions ongoing studies on other RSV prevention options and highlights the need for clear guidelines across Canada. It emphasizes that these new strategies could significantly reduce hospital visits due to RSV in young children and infants.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.